Andrade, Alice O.
Santos, Najara Akira C.
Bastos, Alessandra S.
Pontual, José Daniel C.
Araújo, Cristiane S.
Lima, Analice S.
Martinez, Leandro N.
Ferreira, Amália S.
Aguiar, Anna Caroline C.
Teles, Carolina B. G.
Guido, Rafael V. C.
Santana, Rosa A.
Lopes, Stefanie C. P.
Medeiros, Jansen F.
Rizopoulos, Zaira
Vinetz, Joseph M.
Campo, Brice
Lacerda, Marcus Vinicius G.
Araújo, Maisa S.
Funding for this research was provided by:
Brazilian Ministry of Health/DECIT/CNPq (442653/2019-0, 442653/2019-0, 442653/2019-0, 442653/2019-0, 442653/2019-0)
Medicines for Malaria Venture (MMV RD18-0004-2018, MMV RD18-0004-2018, MMV RD18-0004-2018, MMV RD18-0004-2018, MMV RD18-0004-2018)
Bill & Melinda Gates Foundation (INV-003970, INV-003970)
International Centers of Excellence for Malaria Resea (CON-80002357)
Article History
Received: 4 August 2023
Accepted: 10 October 2023
First Online: 24 October 2023
Competing interests
: The authors declare no competing interests.